New discovery could lead to a treatment for visceral leishmaniasis

FHS
May 21, 2024
6:27 pm

A discovery by Simona Stäger’s team could help come up with a treatment to the most serious form of leishmaniasis.

Risk adjusted net present value: What is the current valuation of AstraZeneca’s Saruparib?

Saruparib is a small molecule commercialized by AstraZeneca, with a leading Phase III program in Metastatic Prostate Cancer.

March 14, 2024

Mathematical relationship between aortic valve and aortic root discovered

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The study was aimed at investigating the mathematical relationship between the aortic valve and

June 27, 2023

Phase 3 study finds inebilizumab effective for immunoglobulin G4–related disease

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating

November 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.